Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) hit a new 52-week high during trading on Monday after StockNews.com upgraded the stock from a hold rating to a buy rating. The stock traded as high as $75.99 and last traded at $75.71, with a volume of 62552 shares changing hands. The stock had […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its target price upped by analysts at Barrington Research from $69.00 to $79.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price target would indicate a potential upside of 6.44% […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its target price hoisted by equities researchers at Barrington Research from $69.00 to $79.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective indicates a potential upside of 6.44% from […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its price objective upped by research analysts at JMP Securities from $72.00 to $77.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “market outperform” rating on the medical instruments supplier’s stock. JMP Securities’ target price indicates a potential upside of 3.75% […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.05, Briefing.com reports. LeMaitre Vascular had a net margin of 15.56% and a return on equity of 10.57%. The business had revenue […]